mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.6 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.6 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.6 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |